Suppr超能文献

经口内镜下肌切开术治疗贲门失弛缓症的长期疗效:一项系统评价和荟萃分析。

Long-term outcomes of peroral endoscopic myotomy for achalasia: a systematic review and meta-analysis.

作者信息

Vespa Edoardo, Pellegatta Gaia, Chandrasekar Viveksandeep T, Spadaccini Marco, Patel Harsh, Maselli Roberta, Galtieri Piera A, Carlani Elisa, Sharma Prateek, Hassan Cesare, Repici Alessandro

机构信息

Department of Gastroenterology and Hepatology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

出版信息

Endoscopy. 2023 Feb;55(2):167-175. doi: 10.1055/a-1894-0147. Epub 2022 Jul 7.

Abstract

BACKGROUND

The long-term outcomes of esophageal peroral endoscopic myotomy (POEM) are still unknown.

METHODS

We searched electronic databases (MEDLINE/PubMed, EMBASE, Scopus) for studies assessing outcomes after POEM for esophageal achalasia with a minimum median follow-up duration of 36 months. Pooled rates of clinical success and postoperative reflux were calculated and compared with the same values at 12/24/36 months when available. Subgroup analyses were performed to explore the interstudy heterogeneity.

RESULTS

From 1528 initial records, 11 studies (2017-2021) were included. A total of 2342 patients (age 48.1 [SD 6.8] years; 50.1 % males) with a median follow-up of 48 months (interquartile range 45-60) were analyzed. The pooled clinical success rate was 87.3 % (95 %CI 83.6 %-91.0 %;  = 73.1 %). The symptomatic reflux pooled rate was 22.0 % (95 %CI 14.4 %-29.5 %;  = 92.7 %). Three cases of peptic strictures and one Barrett's esophagus were reported. The pooled rate of severe adverse events was 1.5 % (95 %CI 0.5 %-2.5 %;  = 52.8 %).

CONCLUSIONS

Long-term clinical efficacy of POEM persisted in 87 % of patients with achalasia. Post-POEM symptomatic reflux remained stable over time. The risk for Barrett's esophagus and peptic strictures appeared minimal.

摘要

背景

经口内镜下食管肌切开术(POEM)的长期疗效尚不清楚。

方法

我们检索了电子数据库(MEDLINE/PubMed、EMBASE、Scopus),以查找评估POEM治疗贲门失弛缓症后疗效的研究,这些研究的最短中位随访时间为36个月。计算临床成功率和术后反流的合并率,并与12/24/36个月时的相同值(如有)进行比较。进行亚组分析以探讨研究间的异质性。

结果

从1528条初始记录中,纳入了11项研究(2017 - 2021年)。共分析了2342例患者(年龄48.1[标准差6.8]岁;男性占50.1%),中位随访时间为48个月(四分位间距45 - 60)。合并临床成功率为87.3%(95%置信区间83.6% - 91.0%;I² = 73.1%)。有症状反流的合并率为22.0%(95%置信区间14.4% - 29.5%;I² = 92.7%)。报告了3例消化性狭窄和1例巴雷特食管。严重不良事件的合并率为1.5%(95%置信区间0.5% - 2.5%;I² = 52.8%)。

结论

POEM对87%的贲门失弛缓症患者具有长期临床疗效。POEM术后有症状反流随时间保持稳定。巴雷特食管和消化性狭窄的风险似乎极小。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验